After spying blockbuster potential in Longboard Pharmaceuticals’ epilepsy med, brain disease-focused pharma Lundbeck is scooping up the biotech for $2.5 billion. At the heart of the buyout is ...
“I have used it on gravel parking lots, sand, rainwater, and grass.” A Hoteel 1200-Watt Electric Longboard is just $330 at Walmart right now, 53% off its normal $700 price tag. The blue model is ...
Longboard Pharmaceuticals Initiates Phase 3 DEEp SEA Study Evaluating Bexicaserin in Dravet Syndrome
LA JOLLA, Calif.--(BUSINESS WIRE)--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological ...
LA JOLLA, Calif.--(BUSINESS WIRE)--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological ...
Longboard Pharmaceuticals LBPH gained 14.4% on Jul 1 after it announced that the FDA has granted Breakthrough Therapy designation for its investigational drug, bexicaserin, to treat seizures ...
Are you looking for the perfect board for you? We've tallied up the biggest differences between a longboard and a skateboard to help you decide. If you don't know much about skateboards or longboards, ...
Longboard Pharmaceuticals LBPH announced that it is set to be acquired by Lundbeck A/S for $60 per share in cash, which brings the total deal value to $2.6 billion equity value and $2.5 billion ...
If you don't know much about skateboards or longboards, it may be tricky to tell the difference between them. Believe it or not, both boards have entirely different uses. When picking which would be ...
The Italian-designed Linky 2.0 takes what was already a pretty cool folding electric longboard and makes it even better in a number of key ways. If its Kickstarter works out, one could soon be yours ...
What do you get when you halve the number of seizures across a group of difficult epilepsy disorders in an early-stage trial? For Longboard Pharmaceuticals, you get a tripling of your share price. The ...
Longboard Pharmaceuticals is being acquired by Lundbeck for $60 per share, valuing the deal at $2.6 billion, driven by the potential of bexicaserin. Bexicaserin shows promising seizure reduction data, ...
Longboard looks like an intriguing play within the biotech sector. The company was spun out of Arena Pharmaceuticals in 2020 - Arena was subsequently acquired by Pfizer in a $6.7bn deal. Arena's lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback